A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 7 February 2024) has been published and includes articles on:
Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine
Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)
Letters and medicine recalls sent to healthcare professionals in January 2024.
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.
The post MHRA Drug Safety Update: February 2024 appeared first on Community Pharmacy England.